Community and Wellness

The Stanford Division of Gastroenterology and Hepatology recently hosted an engaging research forum focused on the rapidly evolving intersection of artificial intelligence (AI) and gastrointestinal (GI) research. Bringing together faculty, fellows, researchers, and staff, the event created a collaborative space for participants to explore how AI is transforming clinical care, translational science, and medical innovation. Through interactive discussions, presentations, and audience-driven surveys, attendees shared their experiences, challenges, and aspirations for integrating AI into their research and clinical work.

The forum highlighted both the excitement and the urgency surrounding AI in medicine. Participants discussed the growing role of AI and machine learning tools in areas such as endoscopy, microbiome research, risk stratification, clinical trials, patient-reported outcomes, and data analysis. Speakers emphasized that AI is not only a tool for improving efficiency, but also a catalyst for entirely new forms of scientific discovery and collaboration. Attendees explored how AI can accelerate research timelines, generate novel hypotheses, improve access to complex datasets, and ultimately help translate discoveries into better patient care more quickly.

A major focus of the event was understanding the barriers researchers currently face in adopting AI. Through live polling and open dialogue, participants identified challenges including limited access to research-ready data, lack of AI training and mentorship, difficulty finding collaborators, and uncertainty about where to begin. Organizers stressed the importance of building educational opportunities, strengthening interdisciplinary partnerships, and creating infrastructure that makes AI tools and datasets more accessible across the division.

Leaders at the forum also spoke about Stanford’s unique opportunity to become a national leader in AI-driven GI research. They emphasized that the university’s collaborative environment, combined with expertise in medicine, engineering, and data science, positions Stanford to drive bold innovation in healthcare. Speakers encouraged attendees to think creatively, pursue ambitious projects, and build collaborative research networks that can shape the future of AI-powered medicine.

In addition to presentations and strategic discussions, the forum fostered meaningful networking and community-building among attendees. Participants were encouraged to continue conversations beyond the event, develop new collaborations, and identify future pilot projects and funding opportunities. By the end of the session, the event had not only showcased the transformative potential of AI in GI research, but also reinforced a shared commitment to innovation, collaboration, and advancing patient-centered care through emerging technologies.